To the Editor: The reemergence of measles in Europe is a reminder of the forgotten risk for severe illness and death associated with this disease in industrialized countries. Since 2008, >20,000 measles cases and 9 measles-associated deaths (in 7 immunocompromised and 2 immunocompetent persons) have been reported to the French Institute for Public Health. Among these cases, the reported causes of death were pneumonia and/or acute respiratory distress syndrome (ARDS) (n = 7) and encephalitis (n = 2). All patients except 1, an immunocompromised patient, had the typical morbillous rash. We report another fatal case of measles, with intractable ARDS but no rash, in an apparently immunocompetent adult.
The patient was a 29-yearold woman in Grenoble, France, who smoked but had no relevant medical history except an episode of depression. In 2011, she sought care for fever, cough, coryza, diarrhea, and a 10-kg weight loss over 10 days. On day 5, because of refractory ARDS, venoarterial extracorporal membrane oxygenation was started. On day 6, the results of a broad serologic investigation demonstrated isolated IgM against measles virus. The patient was additionally given ribavirin, corticosteroids, and intravenous immunoglobulin. On day 10, the lymphocyte level had returned to reference range and the anemia had become regenerative. However, the patient's respiratory condition did not improve, and after 2 weeks of the oxygenation therapy, the patient died of hemorrhagic shock. Her parents declined an autopsy.
PCR testing of the patient's saliva by the French National Reference Center confi rmed the presence of measles virus. Retrospective testing of serum, bone marrow, and BAL specimens collected during days 2-20 of hospitalization demonstrated measles virus RNA. The strain was identifi ed as genotype D4, which is the epidemic strain circulating in France and elsewhere in Europe (1). The patient had no history of enanthem (Koplik spots) or morbilliform rash before or after symptom onset and no documented history of measles vaccination.
Deaths from measles with pneumonia or ARDS but without rash have been reported but mostly in patients with defi cient cell-mediated immunity (2) (3) (4) (5) (6) . Despite all our testing, we found no indications of an underlying immunosuppressive disease in this patient; however, we cannot categorically rule out this possibility, especially that of a primary immunodefi ciency. The initial therapy with corticosteroids and the patient's weight loss could also have interfered with her cellular immune response. The diagnosis of ARDS caused by measles was supported by detection of the measles genome in BAL samples and body fl uids in the absence of any other pathogen, but pulmonary superinfection with unidentifi ed pathogens could not be ruled out. Detection of the measles genome and isolated erythroblastopenia in the bone marrow biopsy sample is consistent with reports that measles virus can infect erythroid progenitors and interfere indirectly with hematopoiesis (7, 8) . Although ribavirin and passive immunotherapy have been reported to aid in recovery from severe measles pneumonia, their clinical effi cacy is still unproven (9,10); and for the patient reported here, they were probably used too late.
This unusual case underscores the need for physicians to consider the diagnosis of measles, even in the absence of classical clinical features, during measles outbreaks. It also reemphasizes the insuffi cient vaccination coverage against measles in France. To the Editor: Multidrug resistance in bacteria isolated from animals is an emerging phenomenon, mirroring what is happening among humans. During the past decade, expanded-spectrum β-lactamases in Enterobacteriaceae from humans (1) and animals (2) worldwide have been reported. Among humans, as a consequence of this high rate, use of carbepenems is increasing selection pressure; carbapenem-resistant gramnegative organisms are increasingly reported, including carbapenemaseproducing Enterobacteriaceae and Acinetobacter spp. (3) .
The most commonly acquired carbapenemases identifi ed in Acinetobacter spp. correspond to carbapenem-hydrolyzing class D β-lactamases (3). In particular, the worldwide spread of OXA-23-producing A. baumannii is considered a serious threat; those strains are frequently involved in nosocomial outbreaks for which therapeutic options are extremely limited (3, 4) . Our study objective was to evaluate the possible occurrence of carbapenemase-producing gramnegative bacteria in dairy cattle in France.
In August 2010, at a dairy farm 30 km from Paris, France, rectal swabs were collected from 50 cows. Samples were precultured in buffered peptone water and incubated for 18 h at 37°C. Cultures were inoculated by streaking 100 μL of the suspensions onto Drigalski agar plates (bioMérieux, Balmes-les-Grottes, France) containing 1 μg/mL of imipenem to select for carbapenem-resistant gramnegative isolates. Of the 50 samples, 9 produced growth on imipenemcontaining plates. All colonies tested (10 colonies/sample) by using the API 20 NE (bioMérieux) system were fi rst identifi ed as A. lwoffi i. Molecular techniques based on sequencing of the gyrA, gyrB, and rpoB genes (5) enabled more precise identifi cation and indicated that all isolates belonged to the Acinetobacter genomospecies (DNA group) 15TU, which is known to be phylogenetically related to A. lwoffi i and which has been reportedly isolated from sewage, freshwater aquaculture habitats, trout intestines, and frozen shrimp (6) .
One colony per sample was retained for further investigation (isolates BY1 to BY9). Susceptibility testing and MIC determinations were performed by disk-diffusion assay (Sanofi -Diagnostic Pasteur, Marnesla-Coquette, France) and Etest (AB bioMérieux, Solna, Sweden) (Table) . All isolates except 1 were resistant to penicillins, combinations of penicillins and β-lactamase inhibitors, and carbapenems but susceptible to cefotaxime and of reduced susceptibility to ceftazidime. Isolate BY1 showed higher MICs for carbapenems (Table) . In addition, all isolates were resistant to tetracycline, kanamycin, and fosfomycin and remained susceptible to fl uoroquinolones, chloramphenicol, gentamicin, amikacin, tobramycin, and sulfonamides. Susceptibility profi les of 3 Acinetobacter genomospecies 15TU reference strains showed that they were fully susceptible to penicillins, carbapenems, tetracycline, and kanamycin.
Clonal diversity between the isolates was assessed by pulsedfi eld gel electrophoresis (5), which showed 6 distinct genotypes. Isolate BY1 corresponded to a single clone (data not shown), which indicated that the occurrence of Acinetobacter genomospecies 15TU strains among these animals was not the result of dissemination of a single clone.
PCR detection and sequencing of genes that encode carbapenemhydrolyzing class D β-lactamases (5) showed that the 9 Acinetobacter genomospecies 15TU isolates harbored a bla OXA-23 gene, whereas the 3 reference strains remained negative. Sequencing confi rmed that all isolates expressed β-lactamase OXA-23, which is known to be widespread in A. baumannii.
Mating-out assays and plasmid electroporation assays were performed by using bla OXA-23 -positive Acinetobacter spp. isolates as donors and rifampin-resistant A. baumannii BM4547 isolates as a recipient strain (5); however, these assays were unsuccessful. Plasmid DNA analysis (5) gave uninterpretable results, with DNA degradations.
The genetic structures surrounding the bla OXA-23 gene were investigated by PCR mapping (7), which identifi ed transposon Tn2008 in isolate BY2 only. Tn2008 is a major vehicle for the spread of the bla OXA-23 gene in A. baumannii in the People's Republic of China (8) and the United States (9). In the other isolates, the ISAba1 element of Tn2008 had been truncated
